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Detection of a Vibrio cholerae DNA-sequence using an optomagnetic read-out exploiting the dynamic
behavior of magnetic nanobeads along with two turn-on data analysis approaches is demonstrated. The
optomagnetic method uses a weak uniaxial AC magnetic ﬁeld of varying frequency applied perpendicular
to the optical path and measures the modulation of laser light passing through a cuvette containing the
sample with oligonucleotide-tagged magnetic beads and macromolecular coils of single-stranded DNA.
The DNA coils are formed upon a padlock probe ligation followed by rolling circle ampliﬁcation (RCA).
The presence of target gives rise to a change of the 2nd harmonic component, V V iV2 2 2= +′ ′′, of the
transmitted light. We demonstrate that by using the phase angle ξ deﬁned as ( )V Varctan /2 2ξ = ′ ′′ in the
low-frequency region we obtain a limit of detection of 10 pM for an RCA time of only 20 min corre-
sponding to a total assay time of 60 min. Moreover, we show that the approach based on ξ is signiﬁcantly
more robust than the analysis based on a turn-off of the signal due to free magnetic nanobeads used in
previous work (Donolato et al., submitted for publication), where a limit of detection of 10 pM was
obtained for an RCA time of 60 min. The increased robustness and the reduction in total assay time
constitute signiﬁcant steps towards the realization of a low-cost, rapid and sensitive biosensor platform
suitable for pathogen detection in both human and veterinary medicine settings.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
There is a growing interest in both industry and academia to
develop simple, cost-efﬁcient and rapid biosensor technologies.
Applications range from ﬁelds such as human and animal health
(Ivnitski et al., 1999; Lazcka et al., 2007; Luppa et al., 2011; San-
vicens et al., 2009; Schmitt and Henderson, 2005; Tothill, 2001;
Wilson and Gifford, 2005), food safety (Amine et al., 2006; Arora
et al., 2011; Ivnitski et al., 2000; Leonard et al., 2003; Mello and
Kubota, 2002; O’Kennedy et al., 2005; Patel, 2002; Van Dorst et al.,
2010; Velusamy et al., 2010), environmental monitoring, including
biological threat agents detection (Amine et al., 2006; Iqbal et al.,
2000; Rodriguez-Mozaz et al., 2004, 2005; Rogers, 1995; Rogers
and Gerlach, 1999; Van Dorst et al., 2010; Velasco-Garcia and
Mottram, 2003) to analysis of drinking water quality (Leonard
et al., 2003; Mello and Kubota, 2002; Noble and Weisberg, 2005;
O’Kennedy et al., 2005). Among the large number of existing
biosensor types, e.g. electrochemical, (Grieshaber et al., 2008;B.V. This is an open access article u
e (M. Strömberg).Pumera et al., 2007) acoustic (Lange et al., 2008) and optical
(Borisov and Wolfbeis, 2008; Fan et al., 2008), magnetic biosensors
are particularly attractive due to a number of unique advantages
(Koh and Josephson, 2009; Llandro et al., 2010). For instance,
magnetic bead labels can be detected with very low background,
their signal is stable over time and the associated read-out
equipment can potentially be made at low cost. This means that
magnetic biodetection devices have great potential to be used in
resource-poor regions of the world (Yager et al., 2008). Also,
magnetic beads could be used to enhance the performance of al-
ready existing biosensors and assays. One such example is the
well-known latex agglutination test (LAT), which utilizes the for-
mation of clusters of functionalized nanobeads as a read-out
method (Ortega-Vinuesa and Bastos-Gonzalez, 2001; Singer and
Plotz, 1956), the limit of detection (LOD) for the traditional LATs is
approximately 1 nM (Baudry et al., 2006; Price and Newman,
1991).
Magnetic biosensors can be divided into two categories; sur-
face-based and volume-based. Surface-based sensors utilize read-
out elements consisting of sensor surfaces, such as magnetor-
esistive thin ﬁlm elements, which can be functionalized with
biomolecules (Janssen et al., 2008; Martins et al., 2009; Wang andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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particles in close vicinity to the sensor surface (Squires et al.,
2008). Volume-based sensors, on the other hand, probe the entire
sample volume. One example of a volume-based sensor is the
optomagnetic sensor, where magnetic bead doublets formed
through probe–target linkage are recognized optically, either
through a change in optical transmittance or scattered light
(Baudry et al., 2006; Park et al., 2009; Ranzoni et al., 2011). An-
other example of volume-based magnetic biosensing is Brownian
relaxation bioassays relying on the change in frequency-depen-
dent magnetic properties of magnetic nanobeads upon binding of
a target analyte to the surface of probe-conjugated magnetic beads
(Astalan et al., 2004; Connolly and Pierre, 2001). In the case of DNA
detection, this change in Brownian relaxation dynamics can be
strongly enhanced by letting detection probe conjugated beads
attach to DNA coils produced by rolling circle ampliﬁcation (RCA)
of circularized DNA formed by padlock probe recognition of the
target DNA (Strömberg et al., 2008). This particular bioassay
method, denoted as the volume-ampliﬁed magnetic nanobead
detection assay (VAM-NDA), makes use of isothermal ampliﬁca-
tion in combination with a homogeneous magnetic read-out,
thereby yielding a high sensitivity and simpliﬁed sample pre-
paration. It should be noted that the padlock probe ligation reac-
tion constitutes highly speciﬁc target recognition since both the 5′
and 3′ ends of the linear padlock probe are designed to base-pair
next to each other on the target strand. The VAM-NDA has been
demonstrated for sensitive (low pM range) detection of bacterial
DNA and spores as well as for studies of drug resistance in
Mycobacterium Tuberculosis (Dalslet et al., 2011; Engström et al.,
2013; de la Torre et al., 2012). However, these studies have used
bulky and/or costly AC susceptometer equipments in most cases.
Recently, one major step towards a miniaturized and low-cost
biodetection platform relying on the VAM-NDA was taken by
demonstrating detection of DNA coils formed from a Vibrio Cho-
lerae DNA target using a novel optomagnetic approach (Donolato
et al., submitted for publication). In this approach the intensity of
light transmitted through a magnetic nanobead dispersion is
modulated by the application of a weak uniaxial AC magnetic ﬁeld.
In the presence of the magnetic ﬁeld, the magnetic nanobeads
align their magnetic moments preferentially along the ﬁeld di-
rection and might also form chain-like structures resulting in aA B
Fig. 1. Panel A displays representative low-frequency V V/2 0′ spectra of samples containin
60 min RCA time and B0¼2.58 mT. Panel B shows turn-on dose–response curves obtaine
points. The error bars correspond to one standard deviation (s.d.) obtained from triplicat
lines show the V V/2 0Δ ′ mean value plus three s.d. (the LOD) obtained for the negative cont
and1 10 4× − have been added to the data to generate the blue and green curves in panel
reader is referred to the web version of this article.)modulation of the transmitted light at twice the frequency of the
magnetic ﬁeld. The ability of the magnetic nanobeads to follow the
AC magnetic ﬁeld depends on their hydrodynamic sizes. Thus,
magnetic nanobeads that are free to rotate can follow the AC
magnetic ﬁeld to higher frequencies than nanobeads bound to
DNA coils. By measuring the modulation of the transmitted laser
light passing through the sample, or to be more precise the de-
pendence of the 2nd harmonic component, V V iV2 2 2= +′ ′′ of the
transmitted light on the frequency of the AC magnetic ﬁeld, the
target analyte concentration can be obtained. It was shown that V2′
exhibits a peak at a frequency related to the Brownian relaxation
frequency of free beads and that an increasing DNA coil con-
centration gives rise to a suppression of the peak amplitude, i.e., a
turn-off effect. A wide range of DNA coil concentrations was con-
sidered (0–1000 pM) and it was shown that concentrations up to
100 pM could be detected and distinguished from each other by
using the dose–response curve. Moreover, using 100 nm beads, a
LOD of 10 pM was achieved. Further information on the under-
lying theory and interpretation can be found in Supplementary
Section S1 and Donolato et al. (submitted for publication).
In this paper we present two novel methodologies to analyze V2
data in a turn-on manner based on (i) the magnitude of V2′ in the
low-frequency region and on (ii) the magnitude of the phase an-
gle, ( )V Varctan /2 2ξ = ′ ′′ , in the low-frequency region. It should be
noted that 2ξ ϕ= , where ϕ is the phase lag of the magnetic re-
sponse with respect to the magnetic ﬁeld excitation; further in-
formation relating to the theoretical model describing the opto-
magnetic response can be found in Supplementary Section S1. We
use two different bead sizes, 100 nm and 250 nm. Furthermore, we
explore the impact on the detection sensitivity varying the bead
concentration, the amplitude of the AC magnetic ﬁeld (B0) and the
enzymatic ampliﬁcation time (RCA time). Overall, we present a
new and reﬁned version of the optomagnetic read-out metho-
dology allowing for more robust measurements and shorter assay
times without sacriﬁcing sensitivity.2. Experimental section
Sequences of targets, padlock probes and detection oligonu-
cleotides can be found in Supplementary material, Table S1.g 100 nm beads (100 μg/ml) and different DNA coil concentrations (NC to 50 pM),
d by taking V V V V V c V c/ (NC)/ (NC) ( )/ ( )2 0 2 0 2 0Δ ′ = ′ − ′ at three different low-frequency
es. The dose–response curves in panel B are color coded and the dashed horizontal
rol sample at the indicated frequencies. Please note that for sake of clarity 0.5 10 4× −
B, respectively. (For interpretation of the references to color in this ﬁgure legend, the
A B
Fig. 2. Panel A shows V V/2 0′ (lower set of curves) and V V/2 0″ (upper set of curves) vs. frequency for three independent negative control samples containing 100 nm beads
(100 μg/ml), B0¼2.58 mT. The curves in panel B show the phase angle V Varctan( / )2 2ξ = ′ ″ vs. frequency. The arctangent function is deﬁned between7π/2. To obtain the phase
curves as shown here, has been subtracted from all phase values below the frequency were the phase switches from π/2 to þπ/2. It should be noted that all three negative
controls exhibit almost identical phase angle spectra as opposed to their V V/2 0 representation.
A C
B D
Fig. 3. Panel A displays ξ vs. frequency curves for samples with different concentrations of DNA coils (NC to 50 pM, 60 min RCA time) and 100 nm particles (100 mg/ml),
B0¼2.58 mT. Panels B to D show c(NC) ( )ξ ξ ξΔ = − vs. DNA coil concentration dose–response curves using different amplitudes of the AC ﬁeld (2.58 mT to 1.42 mT in panels B
to D). The dose–response curves are obtained by taking ξΔ at three different low-frequency points. The error bars indicate one standard deviation (s.d.) based on triplicates.
The dose–response curves in panels B to D are color coded and the dashed horizontal lines show the ξΔ mean values plus three s.d. obtained for the negative control samples
at the indicated frequencies. Please note that for sake of clarity 0.02 and 0.04 have been added to the data to generate the blue and green curves in panels B to D, respectively.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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nanobeads
Conjugations of biotinylated detection probes to 100 nm (BNF-
Starch) and 250 nm (nanomags-D) magnetic beads with avidin
surface (Micromod, Germany) were performed according to pro-
tocols in Supplementary Section S2. The magnetic beads are of
core shell type, where the core consists of a cluster of 5–15 nm
sized maghemite crystals and the shell is made from either hy-
droxyethyl starch (100 nm beads) or dextran (250 nm beads).
Conjugated bead suspensions of 2 mg/ml were further diluted
with PBS to different concentrations (240, 320, 400 and 480 μg/ml
of 100 nm beads; 200 μg/ml of 250 nm beads). Diluted bead sus-
pensions were stored at 4 °C in sealed glass vials.2.2. Padlock probe target recognition, ligation and rolling circle
ampliﬁcation
Solutions of 5 nM DNA coils (V. cholerae (VC) or E. coli (EC))
were synthesized according to protocols in Supplementary Section
S3. Dilution series of DNA coils were prepared by stepwise dilution
of the 5 nM DNA coil solution with hybridization buffer.A C
B D
Fig. 4. ξΔ vs. DNA coil concentration dose–response curves (B0¼2.58 mT, 60 min RCA ti
samples with different concentrations of 100 nm beads (60 μg/ml to 120 μg/ml in panels A
dose–response curves are color coded and the dashed horizontal lines show the ξΔ me
frequencies. Please note that for sake of clarity 0.02 and 0.04 have been added to th
interpretation of the references to color in this ﬁgure legend, the reader is referred to t2.3. Optomagnetic measurement setup
The setup used for optomagnetic measurements is described in
Supplementary Section S4. The output from one measurement is
the total intensity, V0, and the in-phase, V2′ , and out-of-phase, V2″,
components of the complex second harmonic signal of the trans-
mitted light. To compensate for variations in intensity of the laser
light, amount of beads and reﬂection/absorption in the cuvette, all
results of the second harmonic signal were normalized with the
simultaneously measured values of V0.
2.4. Optomagnetic measurements on samples containing DNA coils
and oligonucleotide-tagged magnetic beads
Fifteen microliters of oligonucleotide-tagged bead solution
(240, 320, 400 and 480 μg/ml of 100 nm beads; 200 μg/ml of
250 nm beads) was mixed with ﬁfteen microliters of DNA coil
solution of variable concentration c (4, 20, 40, 80 and 200 pM) or
hybridization buffer in case of negative control (NC). The solution
was incubated for 20 min at 55 °C and thereafter diluted with 30 ml
of a 50–50 buffer mixture (50 v/v % of 1 PBS pH 7.4 and 50 v/v%
of hybridization buffer) followed by transferring the sample so-
lution into a disposable cuvette (UV-Transparent Disposable, Order
No. 67.758, optical path length 10 mm, Sarstedt, Germany). Allme) obtained by taking ξΔ at three different points in the low-frequency region for
to D). The error bars indicate one standard deviation (s.d.) based on triplicates. The
an values plus three s.d. obtained for the negative control samples at the indicated
e data to generate the blue and green curves in panels A to D, respectively. (For
he web version of this article.)
A B
C
Fig. 5. Panels A to C display ξΔ vs. DNA coil concentration dose–response curves for samples with 100 nm beads (100 mg/ml) and different RCA times ranging from 20 to
60 min (B0¼2.58 mT). The error bars indicate one standard deviation (s.d.) based on triplicates. The dose–response. curves are color coded and the dashed horizontal lines
show the ξΔ mean values plus three s.d. obtained for the negative control samples at the indicated frequencies. Please note that for sake of clarity 0.02 and 0.04 have been
added to the data to generate the blue and green curves in panels A to C, respectively. (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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tion after mixing with the magnetic bead suspension and dilution
with 50–50 buffer. Measurements of V2 at room temperature were
performed in the frequency range 1.33–2733 Hz (0.3–300 Hz) for
100 nm (250 nm) bead samples, using different AC magnetic ﬁeld
amplitudes (1.42, 2.00 and 2.58 mT).3. Results and discussion
As mentioned in the introduction, the turn-off type read-out
methodology applied in previous work (Donolato et al., submitted
for publication) gave a limit of detection of around 10 pM for a
bead size of 100 nm and an RCA time of 60 min. In the current
work, the LOD is deﬁned as the lowest tested amount of DNA
yielding a normalized magnetic response differing with more than
three standard deviations when compared to the negative control.
It could be argued that it is generally, in biosensor contexts, more
favorable with a response signal that increases with increasing
analyte concentration. Thus, the next step would be to investigate
different turn-on methodologies to analyze the normalized V2 data.
Furthermore, will such methodologies allow for a shorter assay
time without sacriﬁcing sensitivity? Also, it is highly relevant to
search for more optimal assay conditions than that were was used
in the previous study. With this in mind, we decided to ﬁrstconsider the normalized V2′ spectra in the low-frequency region,
followed by examination of the phase angle spectra (obtained
from the V2′ and V2″ components). Moreover, one important objec-
tive of this study is to make a deeper investigation of how different
experimental settings affect the performance of the assay, such as
LOD, standard deviations and response difference between a NC
and the highest analyte concentration. The parameters we chose
to investigate were bead size, bead concentration, B0 and RCA time.
Fig. 1A shows representative V V/2 0′ spectra for samples with
varying DNA coil concentrations (0–50 pM, 60 min RCA time,
100 mg/ml of 100 nm beads and B0¼2.58 mT). The effect of adding
DNA coils is that the magnitude of the signal increases at low
frequencies (turn-on). This signal change is attributed to magnetic
nanobeads bound to DNA coils. In agreement with previous ob-
servations (Donolato et al., submitted for publication), where the
optomagnetic signal as a function of magnetic bead size was stu-
died, it is noted that the sign of this turn-on signal is opposite to
that due to the free nanobeads. The turn-on effect is explained by
the size-dependent scattering of objects, which depending on the
ratio between the size of the object and the wavelength of light,
may either increase or decrease the transmission when the AC
magnetic ﬁeld attains large values.
The corresponding dose–response curves obtained by taking
V V V V V c V c/ (NC)/ (NC) ( )/ ( )2 0 2 0 2 0Δ = −′ ′ ′ at three different low-fre-
quency points are shown in panel B. With this turn-on metho-
dology, the best LOD for 100 nm beads is 5 pM. However, it was
R.S. Bejhed et al. / Biosensors and Bioelectronics 66 (2015) 405–411410observed that the V V/2 0 spectra within NC triplicates could differ
considerably, especially around the V V/2 0′ peak (see Fig. 2A),
yielding large standard deviations. This motivated a search for an
alternative turn-on approach making use of both V2′ and V2″ data
(see Fig. 2B) based on the phase angle of the V2 signal, which has
recently been used for analysis of magnetorelaxometry data
(Dieckhoff et al., 2014; Schrittwieser et al., 2014). The rationale
behind this method is that both components of V2 will be similarly
affected by changes in effective number of free magnetic nano-
beads due to, e.g., beads adhering to the cuvette walls.
Panel A in Fig. 2 shows V V/2 0′ (lower set of curves) and V V/2 0″
(upper set of curves) vs. frequency obtained for three independent NC
samples based on 100 nm beads with a bead content of 100 mg/ml
(B0¼2.58 mT). The general behavior is in good agreement with the
theory and interpretation described in Supplementary Section S1. As
can be seen, the three V V/2 0″ spectra deviate from each other mainly
at low frequencies, whereas the V V/2 0′ spectra deviate at higher
frequencies. Panel B displays the phase angle, deﬁned as
V Varctan( / )2 2ξ = ′ ″ vs. frequency for the V2 spectra shown in panel A.
The arctangent function is deﬁned between7π2. To obtain the phase
curves as shown here, π has been subtracted from all phase values
below the frequency where the phase switches from π/2 to þπ/2.
As can be seen, the phase angle spectra for the three NC samples
appear almost identical. We therefore consider the phase angle
method as the most robust approach for a turn-on detection.
Fig. S3 shows V V/2 0′ and V V/2 0″ (panel A) and phase angle, ξ,
spectra (panel C) vs. frequency for samples with 250 nm beads
(50 mg/ml) and different concentrations of DNA coils (NC to
50 pM). It should be noted that the spectrum for the NC sample for
the 250 nm beads shows the opposite sign compared to that of the
100 nm beads in agreement with previous observations (Donolato
et al., submitted for publication). Upon increasing DNA coil con-
centration, the spectra show changes similar to those found for the
100 nm beads; the magnitude of the peak due to free magnetic
nanobeads decreases and a signal of opposite sign (now positive)
appears at low frequencies and is particularly clearly observed in
the V V/2 0″ data. Panels B and D display the dose–response curves
V V V c V c V V/ ( )/ ( ) (NC)/ (NC)2 0 2 0 2 0Δ = −′ ′ ′ , taken at the high-frequency
peak, and c(NC) ( )ξ ξ ξΔ = − , taken at three different frequencies in
the low-frequency region, for the 250 nm beads. It can be con-
cluded that an LOD of 20 pM can be reached with both turn-off and
turn-on approaches; however, the sensitivity is not as high as
when using 100 nm beads. Therefore, the optimization work was
conducted solely using 100 nm beads. It may be argued that using
even smaller beads (still exhibiting Brownian relaxation behavior)
could give better detection sensitivity. Smaller beads would allow
for V2 measurements at higher frequencies, thus yielding more
accurate measurements for the same measurement time. How-
ever, going below 100 nm bead size (while using the same type of
multi-core beads of BNF-Starch type) makes the oligonucleotide
conjugation protocol more complicated since the beads cannot be
collected by standard permanent magnets.
Fig. 3A exempliﬁes the turn-on behavior of ξ for a bead size of
100 nm and different DNA coil concentrations when plotted as a
function of frequency. Fig. 3B–D shows phase angle dose–respons
curves vs. DNA coil concentration (60 min RCA time) for different
amplitudes of the AC magnetic ﬁeld (2.58 mT to 1.42 mT in panel B
to D) using 100 nm beads (100 mg/ml). The corresponding phase
angle spectra can be found in Supporting Fig. S4A–C. There seems
to be a trend of slightly improved LOD and also increased response
difference between the NC and 50 pM samples upon increasing
ﬁeld amplitude. We therefore consider it optimal to perform the
read-out at large AC magnetic ﬁeld amplitude.
Fig. 4 presents ξΔ vs. DNA coil concentration dose–response
curves (B0¼2.58 mT, 60 min RCA time) obtained by taking ξΔ at
three different frequencies in the low-frequency regime forsamples with different concentrations of 100 nm beads (60 to
120 mg/ml in panel A to D). The corresponding phase angle vs.
frequency spectra can be found in Supporting Fig. S5, A–D. The
lowest LOD (5 pM) was found for 60, 80 and 100 mg/ml bead
concentrations, but for 100 mg/ml bead concentration, the differ-
ence between the NC sample and the sample with the highest DNA
coil concentration (50 pM) was found to be largest. Therefore, a
bead concentration of 100 mg/ml was considered to be optimal.
Going above 100 mg/ml gives a slightly higher LOD (10 pM).
Moreover, it can be observed that for all considered bead con-
centrations, the obtained LOD is the same for all three frequency-
points.
Fig. 5A–C display ξΔ vs. DNA coil concentration dose–response
curves.
(B0¼2.58 mT) for samples with 100 nm beads (100 mg/ml) and
for different RCA times. It can be observed that the LOD only
slightly increases upon reducing the RCA time (5 pM for 60 min
RCA and 10 pM for 40 and 20 min). In other words, with the phase
angle approach, we reach the same sensitivity for 20 min RCA time
as was obtained for 60 min RCA time in Donolato et al. (submitted
for publication). The corresponding phase angle spectra and re-
lative standard deviations of ξΔ vs. DNA coil concentration can be
found in Supporting Figs. S6 and S7, respectively. The main rea-
sons for maintained sensitivity in the phase angle approach
compared to previous studies (Donolato et al., submitted for
publication) when using only 20 min RCA time are the higher
measurement robustness (see Fig. 2) and the fact that the dose–
response curves are derived from the low-frequency region where
the response from beads bound to DNA coils is located.
Fig. S8 shows V V/2 0′ (panel A), V V/2 0″ (panel B) and phase angle
(panel C) spectra for samples with 250 nm beads (50 mg/ml) and
EC DNA coils (NC, 50 and 500 pM). The beads are functionalized
with oligonucleotides complementary or non-complementary to
the DNA coils. It can be seen that even a very high concentration of
DNA coils non-complementary to the oligonucleotides on the
beads does not give rise to a response change compared to the NC
sample. Therefore, the change of V2 upon varying the DNA coil
concentration is solely due to the binding of beads to DNA coils.
The two turn-on readout principles presented above give rise
to an increase in the low-frequency magnitude of V V/2 0′ and ξ with
increasing DNA coil concentration. According to Fig. 2A in Dono-
lato et al. (submitted for publication, a small change in the total
transmission when the AC magnetic ﬁeld changes from zero to its
maximum value (either positive or negative) can be observed
(Donolato et al., submitted for publication). The sign of the change
is related to whether the magnetic ﬁeld aligned nanobead struc-
tures scatter the light more or less compared to the zero-ﬁeld state
as described in Supplementary Section S1. Moreover, the fre-
quency range where the signal change appears depends inversely
on the hydrodynamic volume of the relaxing entities and thus
magnetic nanobeads bound to DNA coils give rise to a change in
the signal at much lower frequencies compared to free magnetic
nanobeads. This explains the increase of the magnitude of ξ in the
low-frequency region upon increasing DNA coil concentration. In
other words, at intermediate to low frequencies, beads bound in
DNA coils are able to respond to the AC magnetic ﬁeld, but with a
phase lag. These coil bound beads give rise to the increase in the
magnitude of V V/2 0′ , and a corresponding decrease in the magni-
tude of V V/2 0″ , at intermediate and low frequencies, with increasing
DNA coil concentration. Both an increase in V V/2 0′ and a decrease in
V V/2 0″ will increase ξ. At low enough frequencies, the increase in
V V/2 0′ turns into a decrease. It can be argued that this is an in-
dication of that at low enough frequencies V V/2 0′ will approach zero
and the coil bound beads would also be in phase with the AC
magnetic ﬁeld. Thus, for low enough frequencies ξ will approach
the value of π .
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We have successfully demonstrated two turn-on data analysis
approaches for detection of V. cholerae DNA coils with a sensitivity
of 5 pM. Optimal conditions were found through a systematic
change of experimental parameters. The best LOD was reached by
using 100 nm sized magnetic beads at a concentration of 100 mg/ml,
AC magnetic ﬁeld amplitude of 2.58 mT and 60 min of RCA time.
The ﬁrst analysis approach, based on the magnitude of V V/2 0′ in the
low-frequency region, exhibits a sensitivity of 5 pM, but the mag-
nitude of the standard deviations is considered too large. Since
variations between NC triplicates were observed in both the real
and imaginary parts of the V V/2 0 spectra, an assumption was made
that some of these variations would be canceled out by an analysis
approach taking both components of V2 into consideration. Thus,
the second analysis approach makes use of the phase angle of theV2
spectra. Also with this approach, the ideal conditions were found to
be 100 nm sized magnetic beads at a concentration of 100 mg/ml, AC
magnetic ﬁeld amplitude of 2.58 mT and 60 min of RCA time. Using
the phase angle approach, the magnitude of the standard deviations
was found to be signiﬁcantly lower, although the LOD remained at
5 pM. Surprisingly, the sensitivity loss for detection of smaller DNA
coils was almost negligible, opening up for the possibility to sig-
niﬁcantly shorten the whole assay time.
Overall, we have been able to demonstrate a new and reﬁned
version of the optomagnetic methodology, thereby taking steps
further to the realization of a low-cost, rapid and sensitive bio-
sensor platform suitable for pathogen detection in both human
and veterinary medicine settings. Our next step will be to use this
optimized system for detecting pathogenic bacteria using either
the molecular protocols in the present work or an im-
munomagnetic approach. The current challenge in translating
molecular diagnostics assays into a miniaturized format compa-
tible with point-of care setting lies in the complexity of the sample
preparation, DNA ampliﬁcation process and the cost of the reader
module, generally based on ﬂuorescence. This work and the pre-
sented optomagnetic system tackle the challenge of simplifying
the detection part, since it relies only on standard optical com-
ponents and an electromagnet. The use of commercial magnetic
nanobeads functionalized with complementary probes used in a
homogeneous assay format circumvents the need for chip surface
functionalization and washing. Moreover, the method has the
distinct advantage of being compatible with any transparent mi-
croﬂuidic chip. Thanks to the presented advances, the LOD and
dynamic range accessed in just 20 min ampliﬁcation are compar-
able with current standard methods. Therefore the presented
methodology holds a great potential to be integrated into an iso-
thermal ampliﬁcation-based molecular diagnostics device.Acknowledgments
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